CXCL10 and basal cell carcinoma: Both CXCL10 and its receptor CXCR3 are on the other hand over-expressed in many tumours and have been connected to poor prognosis and metastasis in a number of cancers, including colon cancer, multiple myeloma, breast cancer and basal cell carcinoma [40–44].